<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">35434240</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>06</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">2352-5878</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>32</Volume>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>JPRAS open</Title>
          <ISOAbbreviation>JPRAS Open</ISOAbbreviation>
        </Journal>
        <ArticleTitle>History of breast implants: Back to the future.</ArticleTitle>
        <Pagination>
          <StartPage>166</StartPage>
          <EndPage>177</EndPage>
          <MedlinePgn>166-177</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jpra.2022.02.004</ELocationID>
        <Abstract>
          <AbstractText>Modern breast implants are a staple of plastic surgery, finding uses in esthetic and reconstructive procedures. Their history began in the 1960s, with the first generation of smooth devices with thick silicone elastomer, thick silicone gel, and Dacron patches on the back. They presented hard consistency, high capsular contracture rates and the patches increased the risk of rupture. In the same decade, polyurethane coating of implants was implemented. A second generation was introduced in the 1970s with a thinner shell, less viscous gel filler and no patches, but increased silicone bleed-through and rupture rates. The third generation, in the early 1980s, featured implants with a thicker multilayered elastomer shell reinforced with silica to reduce rupture risk and prevent silicone bleed-through. A fourth generation from the late 1980s combined thick outer elastomer shells, more cohesive gel filler, and implemented for the first-time outer shell texturing. In the early 1990s, the fifth generation of devices pioneered an anatomical shape with highly cohesive form-stable gel filler and a rough outer shell surface. Surface texturing was hampered by the discovery of Breast Implant Associated-Anaplastic Large Cell Lymphoma and its link with textured devices. From the 2010s, we have the era of the sixth generation of implants, featuring innovations regarding the surface, with biomimetic surfaces, more resistant shells and variations in gel consistency. The road to innovation comprises setbacks such as the FDA moratorium in 1992, the PIP scandal, the Silimed CE mark temporary suspension and the FDA-requested voluntary recall of the Allergan BIOCELL implants.</AbstractText>
          <CopyrightInformation>© 2022 The Author(s).</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>di Pompeo</LastName>
            <ForeName>Fabio Santanelli</ForeName>
            <Initials>FS</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine and Psychology, Department NESMOS (Neurosciences, Mental Health and Sensory Functions) - Sant'Andrea Hospital, Sapienza University of Rome, Via di Grottarossa 1035-1039, Rome 00189, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Paolini</LastName>
            <ForeName>Guido</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine and Psychology, Department NESMOS (Neurosciences, Mental Health and Sensory Functions) - Sant'Andrea Hospital, Sapienza University of Rome, Via di Grottarossa 1035-1039, Rome 00189, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Firmani</LastName>
            <ForeName>Guido</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine and Psychology, Sapienza University of Rome - Sant'Andrea Hospital, Via di Grottarossa 1035-1039, Rome 00189, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sorotos</LastName>
            <ForeName>Michail</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine and Psychology, Department NESMOS (Neurosciences, Mental Health and Sensory Functions) - Sant'Andrea Hospital, Sapienza University of Rome, Via di Grottarossa 1035-1039, Rome 00189, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>03</Month>
          <Day>11</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>JPRAS Open</MedlineTA>
        <NlmUniqueID>101680420</NlmUniqueID>
        <ISSNLinking>2352-5878</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">BI, Breast Implant</Keyword>
        <Keyword MajorTopicYN="N">BIA-ALCL</Keyword>
        <Keyword MajorTopicYN="N">BIA-ALCL, Breast Implant Associated Anaplastic Large Cell Lymphoma</Keyword>
        <Keyword MajorTopicYN="N">Breast implant history</Keyword>
        <Keyword MajorTopicYN="N">Breast implants</Keyword>
        <Keyword MajorTopicYN="N">Implant design</Keyword>
        <Keyword MajorTopicYN="N">Silicone implants</Keyword>
      </KeywordList>
      <CoiStatement>The Corresponding author would like to disclose that he received reimbursements for travel/lodgment expenses from ICEAG in 2015 and SCHEER-WG in 2019, 2020 and 2021, is a member of Notified Body 0373, part of the Superior Institute of Health, carrying out CE Mark certification activities for the Italian Ministry of Health for the year 2021, and Consultant for Bellaseno GmbH for the year 2021 and 2022. He has no ownerships or investments to disclose. All other authors hereby certify, that to the best of their knowledge no financial support or benefits has been received, neither by themselves directly, nor by any member of their immediate family or any individual or entity with whom or with which they may have a significant relationship from any commercial source which is related directly or indirectly to the scientific work which is reported on in the article. None of the authors has a financial interest in any of the products, devices, or drugs mentioned in this manuscript.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>41</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35434240</ArticleId>
        <ArticleId IdType="pmc">PMC9006741</ArticleId>
        <ArticleId IdType="doi">10.1016/j.jpra.2022.02.004</ArticleId>
        <ArticleId IdType="pii">S2352-5878(22)00013-4</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>International Organization for Standardization. 2018. ISO 14607:2018(en) - non-active surgical implants — mammary implants — particular requirements. [online] Available at: https://www.iso.org/obp/ui/#iso:std:iso:14607:ed-3:v2:en [Accessed 6 January 2022].</Citation>
        </Reference>
        <Reference>
          <Citation>Barr S., Hill E.W., Bayat A. Functional biocompatibility testing of silicone breast implants and a novel classification system based on surface roughness. J Mech Behav Biomed Mater. 2017;5:75–81. Nov; 7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28697402</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Atlan M., Nuti G., Wang H., Decker S., Perry T. Breast implant surface texture impacts host tissue response. J Mech Behav Biomed Mater. 2018:377–385. Dec; 88.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30205325</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jones P., Mempin M., Hu H., et al.  The functional influence of breast implant outer shell morphology on bacterial attachment and growth. Plast Reconstr Surg. 2018;142(4):837–849.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30252806</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maxwell G.P., Gabriel A. Breast implant design. Gland Surg. 2017;6(2):148–153. doi: 10.21037/gs.2016.11.09.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.21037/gs.2016.11.09</ArticleId>
            <ArticleId IdType="pmc">PMC5409902</ArticleId>
            <ArticleId IdType="pubmed">28497018</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Derby B.M., Codner M.A. Textured silicone breast implant use in primary augmentation: core data update and review. Plast Reconstr Surg. 2015;135(1):113–124. doi: 10.1097/PRS.0000000000000832.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/PRS.0000000000000832</ArticleId>
            <ArticleId IdType="pubmed">25539301</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bondurant S., Ernster V., Herdman R., Institute of Medicine (US) Committee on the Safety of Silicone Breast Implants  . Vol. 2. National Academies Press (US); Washington (DC): 1999.  (Safety of Silicone Breast Implants). Silicone Chemistry. Available from:  https://www.ncbi.nlm.nih.gov/books/NBK44788/</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20669503</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spear S.L., Jespersen M.R. Breast implants: saline or silicone? Aesthet Surg J. 2010;30(4):557–570. doi: 10.1177/1090820X10380401.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/1090820X10380401</ArticleId>
            <ArticleId IdType="pubmed">20829254</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maxwell G.P., Gabriel A. The evolution of breast implants. Clin Plast Surg. 2009;36(1):1–v. doi: 10.1016/j.cps.2008.08.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cps.2008.08.001</ArticleId>
            <ArticleId IdType="pubmed">19055956</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Williams J.E. Experiences with a large series of silastic breast implants. Plast Reconstr Surg. 1972;49(3):253–258. doi: 10.1097/00006534-197203000-00002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00006534-197203000-00002</ArticleId>
            <ArticleId IdType="pubmed">5060314</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McGrath M.H., Burkhardt B.R. The safety and efficacy of breast implants for augmentation mammaplasty. Plast Reconstr Surg. 1984;74(4):550–560. doi: 10.1097/00006534-198410000-00019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00006534-198410000-00019</ArticleId>
            <ArticleId IdType="pubmed">6385039</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Handel N., Gutierrez J. Long-term safety and efficacy of polyurethane foam-covered breast implants. Aesthet Surg J. 2006;26(3):265–274. doi: 10.1016/j.asj.2006.04.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.asj.2006.04.001</ArticleId>
            <ArticleId IdType="pubmed">19338905</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ashley F.L. Further studies on the natural-Y breast prosthesis. Plast Reconstr Surg. 1972;49(4):414–419. doi: 10.1097/00006534-197204000-00009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00006534-197204000-00009</ArticleId>
            <ArticleId IdType="pubmed">5014701</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Middleton M.S., McNamara M.P. Breast implant classification with MR imaging correlation: (CME available on RSNA link) Radiographics. 2000;20(3):E1. doi: 10.1148/radiographics.20.3.g00mae11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1148/radiographics.20.3.g00mae11</ArticleId>
            <ArticleId IdType="pubmed">10835136</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barr S., Bayat A. Breast implant surface development: perspectives on development and manufacture. Aesthet Surg J. 2011;31(1):56–67. doi: 10.1177/1090820X10390921.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/1090820X10390921</ArticleId>
            <ArticleId IdType="pubmed">21239673</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Feng L.J., Amini S.B. Analysis of risk factors associated with rupture of silicone gel breast implants. Plast Reconstr Surg. 1999;104(4):955–963. doi: 10.1097/00006534-199909040-00009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00006534-199909040-00009</ArticleId>
            <ArticleId IdType="pubmed">10654733</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peters W. Current status of breast implant survival properties and the management of the woman with silicone gel breast implants. Can J Plast Surg. 2000;8(2):54–67. doi: 10.1177/229255030000800201.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/229255030000800201</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Palley H.A. The evolution of FDA policy on silicone breast implants: a case study of politics, bureaucracy, and business in the process of decision-making. Int J Health Serv. 1995;25(4):573–591. doi: 10.2190/QGG6-XCDX-F830-94AX.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2190/QGG6-XCDX-F830-94AX</ArticleId>
            <ArticleId IdType="pubmed">8575864</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hartley J.H. Specific applications of the double lumen prosthesis. Clin Plast Surg. 1976;3(2):247–263.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1261180</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Becker H. Breast reconstruction using an inflatable breast implant with detachable reservoir. Plast Reconstr Surg. 1984;73(4):678–683. doi: 10.1097/00006534-198404000-00031.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00006534-198404000-00031</ArticleId>
            <ArticleId IdType="pubmed">6709750</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>US Food and Drug Administration. 2020. Saline, silicone gel, and alternative breast implants, guidance for industry and food and drug administration staff. [online] Available at: https://www.fda.gov/media/71081/download [Accessed 5 December 2021].</Citation>
        </Reference>
        <Reference>
          <Citation>Batich C., Williams J., King R. Toxic hydrolysis product from a biodegradable foam implant. J Biomed Mater Res. 1989;23(A3 Suppl):311–319. doi: 10.1002/jbm.820231406.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jbm.820231406</ArticleId>
            <ArticleId IdType="pubmed">2613741</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hester T.R., Ford N.F., Gale P.J., et al.  Measurement of 2,4-toluenediamine in urine and serum samples from women with Même or Replicon breast implants. Plast Reconstr Surg. 1997;100(5):1291–1298. doi: 10.1097/00006534-199710000-00035.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00006534-199710000-00035</ArticleId>
            <ArticleId IdType="pubmed">9326795</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fewtrell L., Bartram J.  IWA Publishing; 2001. Water Quality: Guidelines, Standards and Health. Accessed October 17, 2021  https://apps.who.int/iris/handle/10665/42442.</Citation>
        </Reference>
        <Reference>
          <Citation>U.S. Food and Drug Administration. 2004. FDA breast implant consumer handbook 2004: timeline of breast implant activities. [online] Available at: http://www.professor-graf.de/tl_files/professor-graf/Infos/Aesthetik/fdabreastprosthesis.pdf [Accessed 19 December 2021].</Citation>
        </Reference>
        <Reference>
          <Citation>Van Zele D., Heymans O. Breast implants. A review. Acta Chir Belg. 2004;104(2):158–165. doi: 10.1080/00015458.2004.11679528.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/00015458.2004.11679528</ArticleId>
            <ArticleId IdType="pubmed">15154572</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Castel N., Soon-Sutton T., Deptula P., Flaherty A., Parsa F.D. Polyurethane-coated breast implants revisited: a 30-year follow-up. Arch Plast Surg. 2015;42(2):186–193. doi: 10.5999/aps.2015.42.2.186.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5999/aps.2015.42.2.186</ArticleId>
            <ArticleId IdType="pmc">PMC4366700</ArticleId>
            <ArticleId IdType="pubmed">25798390</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hedén P., Bronz G., Elberg J.J., et al.  Long-term safety and effectiveness of style 410 highly cohesive silicone breast implants. Aesthet Plast Surg. 2009;33(3):430–438. doi: 10.1007/s00266-009-9360-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00266-009-9360-x</ArticleId>
            <ArticleId IdType="pmc">PMC2693778</ArticleId>
            <ArticleId IdType="pubmed">19437071</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Neaman K.C., Albert M., Hammond D.C. Rupture rate and patterns of shell failure with the McGhan Style 153 double-lumen breast implant. Plast Reconstr Surg. 2011;127(1):47–53. doi: 10.1097/PRS.0b013e3181fad248.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/PRS.0b013e3181fad248</ArticleId>
            <ArticleId IdType="pubmed">21200199</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schleiter K.E. Silicone breast implant litigation. Virtual Mentor. 2010;12(5):389–394. doi: 10.1001/virtualmentor.2010.12.5.hlaw1-1005. Published 2010 May 1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/virtualmentor.2010.12.5.hlaw1-1005</ArticleId>
            <ArticleId IdType="pubmed">23158391</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kessler D.A. The basis of the FDA's decision on breast implants. N Engl J Med. 1992;326(25):1713–1715. doi: 10.1056/NEJM199206183262525.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJM199206183262525</ArticleId>
            <ArticleId IdType="pubmed">1309171</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Calobrace M.B., Capizzi P.J. The biology and evolution of cohesive gel and shaped implants. Plast Reconstr Surg. 2014;134(1 Suppl):6S–11S. doi: 10.1097/PRS.0000000000000347.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/PRS.0000000000000347</ArticleId>
            <ArticleId IdType="pubmed">25057753</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bondurant S., Ernster V., Herdman R., Institute of Medicine (US) Committee on the Safety of Silicone Breast Implants  . Vol. 3. National Academies Press (US); Washington (DC): 1999.  (Safety of Silicone Breast Implants). Implant Catalogue. Available from:  https://www.ncbi.nlm.nih.gov/books/NBK44794/</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20669503</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bernstein D.E. Review: the breast implant fiasco. Calif Law Rev. 1999;87(2):457–510.</Citation>
        </Reference>
        <Reference>
          <Citation>Berkel H., Birdsell D.C., Jenkins H. Breast augmentation: a risk factor for breast cancer? N Engl J Med. 1992;326(25):1649–1653. doi: 10.1056/NEJM199206183262501.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJM199206183262501</ArticleId>
            <ArticleId IdType="pubmed">1588977</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gabriel S.E., O'Fallon W.M., Kurland L.T., Beard C.M., Woods J.E., Melton L.J. Risk of connective-tissue diseases and other disorders after breast implantation. N Engl J Med. 1994;330(24):1697–1702. doi: 10.1056/NEJM199406163302401.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJM199406163302401</ArticleId>
            <ArticleId IdType="pubmed">8190133</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sánchez-Guerrero J., Colditz G.A., Karlson E.W., Hunter D.J., Speizer F.E., Liang M.H. Silicone breast implants and the risk of connective-tissue diseases and symptoms. N Engl J Med. 1995;332(25):1666–1670. doi: 10.1056/NEJM199506223322502.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJM199506223322502</ArticleId>
            <ArticleId IdType="pubmed">7760867</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Watad A., Rosenberg V., Tiosano S., et al.  Silicone breast implants and the risk of autoimmune/rheumatic disorders: a real-world analysis. Int J Epidemiol. 2018;47(6):1846–1854. doi: 10.1093/ije/dyy217.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/ije/dyy217</ArticleId>
            <ArticleId IdType="pubmed">30329056</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Coroneos C.J., Selber J.C., Offodile A.C., Butler C.E., Clemens M.W. US FDA breast implant postapproval studies: long-term outcomes in 99,993 patients. Ann Surg. 2019;269(1):30–36. doi: 10.1097/SLA.0000000000002990.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/SLA.0000000000002990</ArticleId>
            <ArticleId IdType="pubmed">30222598</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cunningham B., McCue J. Safety and effectiveness of mentor's MemoryGel implants at 6 years. Aesthet Plast Surg. 2009;33(3):440–444. doi: 10.1007/s00266-009-9364-6. [published correction appears in Aesthetic Plast Surg. 2009 May;33(3):439]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00266-009-9364-6</ArticleId>
            <ArticleId IdType="pubmed">19437068</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spear S.L., Murphy D.K., Slicton A., Walker P.S., Inamed Silicone Breast Implant U.S. Study Group  Inamed silicone breast implant core study results at 6 years. Plast Reconstr Surg. 2007;120(7 Suppl 1):8S–16S. doi: 10.1097/01.prs.0000286580.93214.df.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/01.prs.0000286580.93214.df</ArticleId>
            <ArticleId IdType="pubmed">18090808</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jewell M.L., Bengtson B.P., Smither K., Nuti G., Perry T. Physical properties of silicone gel breast implants. Aesthet Surg J. 2019;39(3):264–275. doi: 10.1093/asj/sjy103. [published correction appears in Aesthet Surg J. 2019 Nov 13;39(12):NP552-NP553]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/asj/sjy103</ArticleId>
            <ArticleId IdType="pmc">PMC6376345</ArticleId>
            <ArticleId IdType="pubmed">29718087</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gabriel A., Manahan M., Colwell A.S. Introduction to "management of patients with textured implants". Plast Reconstr Surg. 2021;147(5S):5S–6S. doi: 10.1097/PRS.0000000000008038.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/PRS.0000000000008038</ArticleId>
            <ArticleId IdType="pubmed">33890874</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Atlan M., Nuti G., Wang H., Decker S., Perry T. Breast implant surface texture impacts host tissue response. J Mech Behav Biomed Mater. 2018;88:377–385. doi: 10.1016/j.jmbbm.2018.08.035.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jmbbm.2018.08.035</ArticleId>
            <ArticleId IdType="pubmed">30205325</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Duteille F., Perrot P., Bacheley M.H., Bell E., Stewart S. Ten-year safety data for eurosilicone's round and anatomical silicone gel breast implants. Aesthet Surg J Open Forum. 2019;1(2):ojz012. doi: 10.1093/asjof/ojz012. Published 2019 Apr 27.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/asjof/ojz012</ArticleId>
            <ArticleId IdType="pmc">PMC7671289</ArticleId>
            <ArticleId IdType="pubmed">33791608</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chao A.H., Garza R., Povoski S.P. A review of the use of silicone implants in breast surgery. Expert Rev Med Devices. 2016;13(2):143–156. doi: 10.1586/17434440.2016.1134310.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1586/17434440.2016.1134310</ArticleId>
            <ArticleId IdType="pubmed">26690709</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perry D., Frame J.D. The history and development of breast implants. Ann R Coll Surg Engl. 2020;102(7):478–482. doi: 10.1308/rcsann.2020.0003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1308/rcsann.2020.0003</ArticleId>
            <ArticleId IdType="pmc">PMC7450417</ArticleId>
            <ArticleId IdType="pubmed">31964154</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zuckerman D., Booker N., Nagda S. Public health implications of differences in U.S. and European Union regulatory policies for breast implants. Reprod Health Matters. 2012;20(40):102–111. doi: 10.1016/S0968-8080(12)40662-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0968-8080(12)40662-0</ArticleId>
            <ArticleId IdType="pubmed">23245415</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rizkalla M., Duncan C., Matthews R.N. Trilucent breast implants: a 3 year series. Br J Plast Surg. 2001;54(2):125–127. doi: 10.1054/bjps.2000.3490.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1054/bjps.2000.3490</ArticleId>
            <ArticleId IdType="pubmed">11207121</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Monstrey S., Christophe A., Delanghe J., et al.  What exactly was wrong with the Trilucent breast implants? A unifying hypothesis. Plast Reconstr Surg. 2004;113(3):847–856. doi: 10.1097/01.prs.0000105337.12656.dc.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/01.prs.0000105337.12656.dc</ArticleId>
            <ArticleId IdType="pubmed">15108875</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berry M.G., Davies D.M. Breast augmentation: part I–A review of the silicone prosthesis. J Plast Reconstr Aesthet Surg. 2010;63(11):1761–1768. doi: 10.1016/j.bjps.2009.07.047.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bjps.2009.07.047</ArticleId>
            <ArticleId IdType="pubmed">19713165</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR). 2014. The safety of poly implant prothèse (PIP) silicone breast implants - update of the opinion of February 2012. [online] Available at: https://ec.europa.eu/health/scientific_committees/emerging/docs/scenihr_o_043.pdf [Accessed 29 December 2021], doi: 10.2772/66097</Citation>
        </Reference>
        <Reference>
          <Citation>Daniels A.U. Silicone breast implant materials. Swiss Med Wkly. 2012;142:w13614. doi: 10.4414/smw.2012.13614. Published 2012 Jul 23.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4414/smw.2012.13614</ArticleId>
            <ArticleId IdType="pubmed">22826101</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lampert F.M., Schwarz M., Grabin S., Stark G.B. The ``PIP scandal'' - complications in breast implants of inferior quality: state of knowledge, official recommendations and case report. Geburtshilfe Frauenheilkd. 2012;72(3):243–246. doi: 10.1055/s-0031-1298323.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/s-0031-1298323</ArticleId>
            <ArticleId IdType="pmc">PMC4168359</ArticleId>
            <ArticleId IdType="pubmed">25308983</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>K Groth A., Graf R. Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) and the textured breast implant crisis. Aesthet Plast Surg. 2020;44(1):1–12. doi: 10.1007/s00266-019-01521-3. [published correction appears in Aesthetic Plast Surg. 2020 Oct;44(5):1951]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00266-019-01521-3</ArticleId>
            <ArticleId IdType="pubmed">31624894</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lahiri A., Waters R. Locoregional silicone spread after high cohesive gel silicone implant rupture. J Plast Reconstr Aesthet Surg. 2006;59(8):885–886. doi: 10.1016/j.bjps.2005.12.014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bjps.2005.12.014</ArticleId>
            <ArticleId IdType="pubmed">16876092</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Silver R.M., Sahn E.E., Allen J.A., et al.  Demonstration of silicon in sites of connective-tissue disease in patients with silicone-gel breast implants. Arch Dermatol. 1993;129(1):63–68.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8420493</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Noone R.B. A review of the possible health implications of silicone breast implants. Cancer. 1997;79(9):1747–1756. doi: 10.1002/(sici)1097-0142(19970501)79:9&lt;1747::aid-cncr17&gt;3.0.co;2-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/(sici)1097-0142(19970501)79:9&lt;1747::aid-cncr17&gt;3.0.co;2-y</ArticleId>
            <ArticleId IdType="pubmed">9128992</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BBC News. 2017. PIP breast implants: French court tells TUV to pay damages. [online] Available at: https://www.bbc.com/news/world-europe-38692678 [Accessed 6 December 2021].</Citation>
        </Reference>
        <Reference>
          <Citation>Martindale V., Menache A. The PIP scandal: an analysis of the process of quality control that failed to safeguard women from the health risks. J R Soc Med. 2013;106(5):173–177. doi: 10.1177/0141076813480994.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/0141076813480994</ArticleId>
            <ArticleId IdType="pmc">PMC3676226</ArticleId>
            <ArticleId IdType="pubmed">23761525</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>French National Agency for the Safety of Medicines and Health Products. 2011. Update of recommendations for women with silicone filled poly implant prosthesis (PIP) breast implants. [online] Available at: https://ansm.sante.fr/uploads/2020/12/22/pip-cp-ministere-actualisation-23122011-en.pdf [Accessed 4 December 2021].</Citation>
        </Reference>
        <Reference>
          <Citation>EUR-Lex (European Union law). 2007. Consolidated versions of the treaty on European Union and the treaty on the functioning of the European Union. [online] Available at: http://data.europa.eu/eli/treaty/tfeu_2012/oj [Accessed 6 January 2022].</Citation>
        </Reference>
        <Reference>
          <Citation>Baan R.A., Grosse Y. Man-made mineral (vitreous) fibres: evaluations of cancer hazards by the IARC monographs programme. Mutat Res. 2004;553(1–2):43–58. doi: 10.1016/j.mrfmmm.2004.06.019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.mrfmmm.2004.06.019</ArticleId>
            <ArticleId IdType="pubmed">15288532</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bernstein D.M. Synthetic vitreous fibers: a review toxicology, epidemiology and regulations. Crit Rev Toxicol. 2007;37(10):839–886. doi: 10.1080/10408440701524592.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/10408440701524592</ArticleId>
            <ArticleId IdType="pubmed">18027165</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>United Kingdom Government. 2015. Suspension of devices manufactured by silimed. [online] Available at: https://www.gov.uk/government/news/suspension-of-devices-manufactured-by-silimed [Accessed 5 December 2021].</Citation>
        </Reference>
        <Reference>
          <Citation>Venhuis B.J., Keizers P., Geertsma R., Woutersen M., Muller A., Pronk M. Dutch National Institute for Public Health and the Environment. RIVM letter report 2015-0202 - risk analysis of particulate contamination on silimed silicone-based breast implants. Published 2015. Accessed October 3, 2021. https://www.rivm.nl/bibliotheek/rapporten/2015-0202.pdf</Citation>
        </Reference>
        <Reference>
          <Citation>Cannon G.J., Swanson J.A. The macrophage capacity for phagocytosis. J Cell Sci. 1992;101(Pt 4):907–913.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1527185</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Therapeutic Goods Administration (TGA). 2017. Silimed medical devices (all - including breast implants). [online] Available at: https://www.tga.gov.au/alert/silimed-medical-devices-all-including-breast-implants [Accessed 5 December 2021].</Citation>
        </Reference>
        <Reference>
          <Citation>Loch-Wilkinson A., Beath K.J., Knight R.J.W., et al.  Breast implant-associated anaplastic large cell lymphoma in Australia and New Zealand: high-surface-area textured implants are associated with increased risk. Plast Reconstr Surg. 2017;140(4):645–654. doi: 10.1097/PRS.0000000000003654.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/PRS.0000000000003654</ArticleId>
            <ArticleId IdType="pubmed">28481803</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Collett D.J., Rakhorst H., Lennox P., Magnusson M., Cooter R., Deva A.K. Current risk estimate of breast implant-associated anaplastic large cell lymphoma in textured breast implants. Plast Reconstr Surg. 2019;143:30S–40S. doi: 10.1097/PRS.0000000000005567. 3S A Review of Breast Implant–Associated Anaplastic Large Cell Lymphoma.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/PRS.0000000000005567</ArticleId>
            <ArticleId IdType="pubmed">30817554</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Magnusson M., Beath K., Cooter R., et al.  The epidemiology of breast implant-associated anaplastic large cell lymphoma in Australia and New Zealand confirms the highest risk for grade 4 surface breast implants. Plast Reconstr Surg. 2019;143(5):1285–1292. doi: 10.1097/PRS.0000000000005500.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/PRS.0000000000005500</ArticleId>
            <ArticleId IdType="pubmed">30789476</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sientra. 2015. Sientra sends letter to plastic surgeons regarding silimed-manufactured products. [online] Available at: https://investors.sientra.com/news/news-details/2015/Sientra-Sends-Letter-to-Plastic-Surgeons-Regarding-Silimed-Manufactured-Products/default.aspx [Accessed 5 December 2021].</Citation>
        </Reference>
        <Reference>
          <Citation>UK's Medicines and Healthcare products Regulatory Agency. 2018. Devices made by silimed - updates from MHRA on the suspension of devices made by silimed. [online] Available at: https://www.gov.uk/government/publications/devices-made-by-silimed [Accessed 6 January 2022].</Citation>
        </Reference>
        <Reference>
          <Citation>Brunnert K.E. The micropolyurethane foam-coated Diagon/Gel(®)4Two implant in aesthetic and reconstructive breast surgery - 3-year results of an ongoing study. GMS Interdiscip Plast Reconstr Surg DGPW. 2015;4 doi: 10.3205/iprs000079. Doc20. Published 2015 Dec 21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3205/iprs000079</ArticleId>
            <ArticleId IdType="pmc">PMC4686800</ArticleId>
            <ArticleId IdType="pubmed">26713264</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Keech J.A., Creech B.J. Anaplastic T-cell lymphoma in proximity to a saline-filled breast implant. Plast Reconstr Surg. 1997;100(2):554–555. doi: 10.1097/00006534-199708000-00065.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00006534-199708000-00065</ArticleId>
            <ArticleId IdType="pubmed">9252643</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>US Food and Drug Administration. 2021. FDA update on the safety of silicone gel-filled breast implants. [online] Available at: https://www.fda.gov/files/medical%20devices/published/Update-on-the-Safety-of-Silicone-Gel-Filled-Breast-Implants-%282011%29.pdf [Accessed 5 December 2021].</Citation>
        </Reference>
        <Reference>
          <Citation>Swerdlow S.H., Campo E., Pileri S.A., et al.  The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375–2390. doi: 10.1182/blood-2016-01-643569.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood-2016-01-643569</ArticleId>
            <ArticleId IdType="pmc">PMC4874220</ArticleId>
            <ArticleId IdType="pubmed">26980727</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scientific Committee on Health Environmental and Emerging Risks (SCHEER). 2017. Scientific advice on The state of scientific knowledge regarding a possible connection between breast implants and anaplastic large cell lymphoma. [online] Available at: https://ec.europa.eu/health/sites/default/files/scientific_committees/scheer/docs/scheer_o_007.pdf [Accessed 6 January 2022].</Citation>
        </Reference>
        <Reference>
          <Citation>Santanelli di Pompeo F., Sorotos M., Clemens M.W., Firmani G. European Association of Plastic Surgeons (EURAPS) Committee on device safety and development. breast implant-associated anaplastic large cell lymphoma (BIA-ALCL): review of epidemiology and prevalence assessment in Europe. Aesthet Surg J. 2021;41(9):1014–1025. doi: 10.1093/asj/sjaa285.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/asj/sjaa285</ArticleId>
            <ArticleId IdType="pubmed">33022037</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Santanelli di Pompeo F., Laporta R., Sorotos M., et al.  Breast implant-associated anaplastic large cell lymphoma: proposal for a monitoring protocol. Plast Reconstr Surg. 2015;136(2):144e–151e. doi: 10.1097/PRS.0000000000001416.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/PRS.0000000000001416</ArticleId>
            <ArticleId IdType="pubmed">26218387</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Singh M., Singh G., Singh Chauhan A., et al.  Impact of FDA updates on public interest in breast implant-associated anaplastic large cell lymphoma. Plast Reconstr Surg Glob Open. 2020;8(11):e3240. doi: 10.1097/GOX.0000000000003240. Published 2020 Nov 23.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/GOX.0000000000003240</ArticleId>
            <ArticleId IdType="pmc">PMC7722577</ArticleId>
            <ArticleId IdType="pubmed">33299706</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Jong W.H., Panagiotakos D., Proykova A., et al.  Final opinion on the safety of breast implants in relation to anaplastic large cell lymphoma: report of the scientific committee on health, emerging and environmental risks (SCHEER) Regul Toxicol Pharmacol. 2021;125 doi: 10.1016/j.yrtph.2021.104982.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.yrtph.2021.104982</ArticleId>
            <ArticleId IdType="pubmed">34214611</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Santanelli di Pompeo F., Paolini G., Firmani G., Sorotos M. From breast implant to rough implant associated-ALCL (RIA-ALCL) Aesthet Surg J. 2022:sjac005. doi: 10.1093/asj/sjac005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/asj/sjac005</ArticleId>
            <ArticleId IdType="pmc">PMC9117088</ArticleId>
            <ArticleId IdType="pubmed">35022649</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Turner S.D., Inghirami G., Miranda R.N., Kadin M.E. Cell of origin and immunologic events in the pathogenesis of breast implant-associated anaplastic large-cell lymphoma. Am J Pathol. 2020;190(1):2–10. doi: 10.1016/j.ajpath.2019.09.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajpath.2019.09.005</ArticleId>
            <ArticleId IdType="pmc">PMC7298558</ArticleId>
            <ArticleId IdType="pubmed">31610171</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>European Union Scientific Committee on Health, Environmental and Emerging Risks (SCHEER). Memorandum on weight of evidence and uncertainties. Published 2018. Accessed October 22, 2021. https://ec.europa.eu/health/sites/default/files/scientific_committees/scheer/docs/scheer_o_014.pdf doi:10.2875/386011</Citation>
        </Reference>
        <Reference>
          <Citation>Cardoso M.J., Wyld L., Rubio I.T., et al.  EUSOMA position regarding breast implant associated anaplastic large cell lymphoma (BIA-ALCL) and the use of textured implants. Breast. 2019;44:90–93. doi: 10.1016/j.breast.2019.01.011. [published correction appears in Breast. 2019 Dec;48:102]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.breast.2019.01.011</ArticleId>
            <ArticleId IdType="pubmed">30703669</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mallucci P., Bistoni G. The use of anatomic implants in aesthetic breast surgery. Clin Plast Surg. 2021;48(1):141–156. doi: 10.1016/j.cps.2020.09.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cps.2020.09.010</ArticleId>
            <ArticleId IdType="pubmed">33220901</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Montemurro P., Tay V.K.S. Transitioning from conventional textured to nanotextured breast implants: our early experience and modifications for optimal breast augmentation outcomes. Aesthet Surg J. 2021;41(2):189–195. doi: 10.1093/asj/sjaa169. [published correction appears in Aesthet Surg J. 2021 Sep 14;41(10):1221]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/asj/sjaa169</ArticleId>
            <ArticleId IdType="pubmed">32582953</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roberts J.M., Carr L.W., Jones A., Schilling A., Mackay D.R., Potochny J.D. A prospective approach to inform and treat 1340 patients at risk for BIA-ALCL. Plast Reconstr Surg. 2019;144(1):46–54. doi: 10.1097/PRS.0000000000005703.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/PRS.0000000000005703</ArticleId>
            <ArticleId IdType="pubmed">31246798</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Calobrace M.B. Elective implant removal and replacement in asymptomatic aesthetic patients with textured devices. Plast Reconstr Surg. 2021;147(5S):14S–23S. doi: 10.1097/PRS.0000000000008041.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/PRS.0000000000008041</ArticleId>
            <ArticleId IdType="pubmed">33890876</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bröstimplantatregistret (BRIMP). 2019. The breast implant register annual report. [online] Available at: https://registercentrum.blob.core.windows.net/brimp/r/BRIMP-Annual-Report-2019-HJeBIdtlJP.pdf [Accessed 19 December 2021].</Citation>
        </Reference>
        <Reference>
          <Citation>Matros E., Shamsunder M.G., Rubenstein R.N., et al.  Textured and smooth implant use reported in the tracking operations and outcomes for plastic surgeons database: epidemiologic implications for BIA-ALCL. Plast Reconstr Surg Glob Open. 2021;9(3):e3499. doi: 10.1097/GOX.0000000000003499.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/GOX.0000000000003499</ArticleId>
            <ArticleId IdType="pmc">PMC7972654</ArticleId>
            <ArticleId IdType="pubmed">33758732</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heidekrueger P.I., Sinno S., Hidalgo D.A., Colombo M., Broer P.N. Current trends in breast augmentation: an international analysis. Aesthet Surg J. 2018;38(2):133–148. doi: 10.1093/asj/sjx104.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/asj/sjx104</ArticleId>
            <ArticleId IdType="pubmed">28591762</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Calobrace M.B., Schwartz M.R., Zeidler K.R., Pittman T.A., Cohen R., Stevens W.G. Long-term safety of textured and smooth breast implants. Aesthet Surg J. 2017;38(1):38–48. doi: 10.1093/asj/sjx157. Dec 13PMID: 29040370.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/asj/sjx157</ArticleId>
            <ArticleId IdType="pubmed">29040370</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cuomo R. The state of the art about etiopathogenetic models on breast implant associated-anaplastic large cell lymphoma (BIA-ALCL): a narrative review. J Clin Med. 2021;10(10):2082. doi: 10.3390/jcm10102082. Published 2021 May 12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/jcm10102082</ArticleId>
            <ArticleId IdType="pmc">PMC8151182</ArticleId>
            <ArticleId IdType="pubmed">34066230</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Doloff J.C., Veiseh O., de Mezerville R., et al.  The surface topography of silicone breast implants mediates the foreign body response in mice, rabbits and humans. Nat Biomed Eng. 2021;5(10):1115–1130. doi: 10.1038/s41551-021-00739-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41551-021-00739-4</ArticleId>
            <ArticleId IdType="pubmed">34155355</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shin B.H., Kim B.H., Kim S., Lee K., Choy Y.B., Heo C.Y. Silicone breast implant modification review: overcoming capsular contracture. Biomater Res. 2018;22:37. doi: 10.1186/s40824-018-0147-5. Published 2018 Dec 20.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s40824-018-0147-5</ArticleId>
            <ArticleId IdType="pmc">PMC6302391</ArticleId>
            <ArticleId IdType="pubmed">30598837</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brown T., Harvie F., Stewart S. A different perspective on breast implant surface texturization and anaplastic large cell lymphoma (ALCL) Aesthet Surg J. 2019;39(1):56–63. doi: 10.1093/asj/sjy091.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/asj/sjy091</ArticleId>
            <ArticleId IdType="pubmed">29659699</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barr S., Hill E., Bayat A. Patterning of novel breast implant surfaces by enhancing silicone biocompatibility, using biomimetic topographies. Eplasty. 2010;10:e31. Published 2010 Apr 26.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2860220</ArticleId>
            <ArticleId IdType="pubmed">20458346</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barr S., Hill E.W., Bayat A. Development, fabrication and evaluation of a novel biomimetic human breast tissue derived breast implant surface. Acta Biomater. 2017;49:260–271. doi: 10.1016/j.actbio.2016.11.052.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.actbio.2016.11.052</ArticleId>
            <ArticleId IdType="pubmed">27919840</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mendonça Munhoz A., Santanelli di Pompeo F., De Mezerville R. Nanotechnology, nanosurfaces and silicone gel breast implants: current aspects. Case Rep Plast Surg Hand Surg. 2017;4(1):99–113. doi: 10.1080/23320885.2017.1407658. Published 2017 Nov 29.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/23320885.2017.1407658</ArticleId>
            <ArticleId IdType="pmc">PMC5727455</ArticleId>
            <ArticleId IdType="pubmed">29250575</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kyle D.J., Oikonomou A., Hill E., Bayat A. Development and functional evaluation of biomimetic silicone surfaces with hierarchical micro/nano-topographical features demonstrates favourable in vitro foreign body response of breast-derived fibroblasts. Biomaterials. 2015;52:88–102. doi: 10.1016/j.biomaterials.2015.02.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biomaterials.2015.02.003</ArticleId>
            <ArticleId IdType="pubmed">25818416</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sforza M., Hammond D.C., Botti G., et al.  Expert consensus on the use of a new bioengineered, cell-friendly, smooth surface breast implant. Aesthet Surg J. 2019;39(Suppl_3):S95–S102. doi: 10.1093/asj/sjz054. [published correction appears in Aesthet Surg J. 2019 May 08;:]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/asj/sjz054</ArticleId>
            <ArticleId IdType="pmc">PMC6460429</ArticleId>
            <ArticleId IdType="pubmed">30958549</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>GC Aesthetics. 2021. Introducing impleo smooth™. [online] Available at: https://www.gcaesthetics.com/wp-content/uploads/2019/07/IMPLEO_Smooth_Visual_Aid.pdf [Accessed 5 December 2021].</Citation>
        </Reference>
        <Reference>
          <Citation>Govrin-Yehudain O., Calderon N., Govrin-Yehudain J. Five year safety and satisfaction with the lightweight breast implant. Aesthet Surg J. 2021:sjab054. doi: 10.1093/asj/sjab054. [published online ahead of print, 2021 Feb 10]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/asj/sjab054</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Duvignac H.  Proceedings of the 3rd World Consensus Conference on BIA-ALCL. 2021. ALCL - France update.https://youtu.be/YYHSUPUyUJs?t=33763 [online] Available at:</Citation>
        </Reference>
        <Reference>
          <Citation>Galstyan A., Bunker M.J., Lobo F., et al.  Applications of 3D printing in breast cancer management. 3D Print Med. 2021;7(1):6. doi: 10.1186/s41205-021-00095-8. [published correction appears in 3D Print Med. 2021 Jul 7;7(1):19] Published 2021 Feb 9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s41205-021-00095-8</ArticleId>
            <ArticleId IdType="pmc">PMC7871648</ArticleId>
            <ArticleId IdType="pubmed">33559793</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cleversey C., Robinson M., Willerth S.M. 3D printing breast tissue models: a review of past work and directions for future work. Micromachines. 2019;10(8):501. doi: 10.3390/mi10080501. (Basel)Published 2019 Jul 27.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/mi10080501</ArticleId>
            <ArticleId IdType="pmc">PMC6723606</ArticleId>
            <ArticleId IdType="pubmed">31357657</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jovic T.H., Combellack E.J., Jessop Z.M., Whitaker I.S. 3D bioprinting and the future of surgery. Front Surg. 2020;7 doi: 10.3389/fsurg.2020.609836. Published 2020 Nov 27.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fsurg.2020.609836</ArticleId>
            <ArticleId IdType="pmc">PMC7728666</ArticleId>
            <ArticleId IdType="pubmed">33330613</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Woodruff M.A., Hutmacher D.W. The return of a forgotten polymer. Polycaprolactone in the 21st century. Prog Polym Sci. 2010;35:1217–1256. doi: 10.1016/j.progpolymsci.2010.04.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.progpolymsci.2010.04.002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Poh P.S., Hege C., Chhaya M.P., et al.  Evaluation of polycaprolactone − poly-D,L-lactide copolymer as biomaterial for breast tissue engineering. Polym Int. 2017;66:77–84. doi: 10.1002/pi.5181.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/pi.5181</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chhaya M.P., Melchels F.P., Holzapfel B.M., Baldwin J.G., Hutmacher D.W. Sustained regeneration of high-volume adipose tissue for breast reconstruction using computer aided design and biomanufacturing. Biomaterials. 2015;52:551–560. doi: 10.1016/j.biomaterials.2015.01.025.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biomaterials.2015.01.025</ArticleId>
            <ArticleId IdType="pubmed">25818460</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
